Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Namestovo

8 clinical trials in Namestovo, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Namestovo at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Namestovo

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not yet recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Dyslipidaemia

Not recruiting
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Namestovo

What the registry says about research in the country

01 Cardiovascular Health Studies

Clinical research focusing on heart failure prevention through combination therapy investigation. Studies evaluate the effectiveness of combining baxdrostat with dapagliflozin to reduce cardiovascular mortality risks.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Combination Therapy Assessment

These trials aim to advance our understanding of preventive treatments for heart conditions.

02 Stroke Prevention Research

Innovative studies examining stroke prevention in patients with atrial fibrillation. The research compares the efficacy of asundexian versus apixaban in preventing stroke and systemic embolism.

  • Atrial Fibrillation Management
  • Stroke Prevention Strategies
  • Bleeding Risk Assessment

Research focuses on developing safer and more effective anticoagulation treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.